oxazoles has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, JR; Carter, PH; Chaudhry, C; Cheng, L; Chimalakonda, A; Chiney, M; Elzinga, PA; Gillooly, KM; Khan, J; Langevine, C; Li, J; Lin, J; Liu, C; Lombardo, LJ; Macor, JE; McIntyre, KW; Ruzanov, M; Shuster, D; Smith, D; Strnad, J; Thankappan, A; Tokarski, JS; Weinstein, DS; Zhang, Y; Zupa-Fernandez, A | 1 |
| Chen, X; Ji, M; Jin, J; Lai, F; Wang, Y; Xue, N; Zhang, S; Zhang, X | 1 |
2 other study(ies) available for oxazoles and Psoriasis
| Article | Year |
|---|---|
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.
Topics: Animals; Catalysis; Crystallography, X-Ray; Cyclopropanes; Drug Discovery; Humans; Mice; Oxazoles; Protein Binding; Protein Kinase Inhibitors; Psoriasis; Structure-Activity Relationship; TYK2 Kinase | 2021 |
Validating a Selective S1P
Topics: Administration, Oral; Animals; Animals, Outbred Strains; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; Guinea Pigs; Mice; Mitotic Index; Mucous Membrane; Oxazoles; Propanolamines; Psoriasis; Random Allocation; Receptors, Lysosphingolipid; Reproducibility of Results; Skin; Specific Pathogen-Free Organisms; Sphingosine-1-Phosphate Receptors; Vagina | 2018 |